Cargando…

The potential role of the three-dimensional-bioprinting model in screening and developing drugs

Recently, we have read with great interest the original article used different spatial configuration models of colorectal cancer (CRC) for validating the anti-tumor efficacy with Diiminoquinone. We feel obliged to provide new insight into the drug screening models by integrating and analyzing the or...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Chao-Lin, Wu, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813933/
https://www.ncbi.nlm.nih.gov/pubmed/36620341
http://dx.doi.org/10.3748/wjg.v28.i47.6788
_version_ 1784864024361435136
author Deng, Chao-Lin
Wu, Bin
author_facet Deng, Chao-Lin
Wu, Bin
author_sort Deng, Chao-Lin
collection PubMed
description Recently, we have read with great interest the original article used different spatial configuration models of colorectal cancer (CRC) for validating the anti-tumor efficacy with Diiminoquinone. We feel obliged to provide new insight into the drug screening models by integrating and analyzing the original method and result. These comments may provide comprehensive insights into three-dimensional drug screening models and the difference between pathologic subtypes in CRC.
format Online
Article
Text
id pubmed-9813933
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-98139332023-01-06 The potential role of the three-dimensional-bioprinting model in screening and developing drugs Deng, Chao-Lin Wu, Bin World J Gastroenterol Letter to the Editor Recently, we have read with great interest the original article used different spatial configuration models of colorectal cancer (CRC) for validating the anti-tumor efficacy with Diiminoquinone. We feel obliged to provide new insight into the drug screening models by integrating and analyzing the original method and result. These comments may provide comprehensive insights into three-dimensional drug screening models and the difference between pathologic subtypes in CRC. Baishideng Publishing Group Inc 2022-12-21 2022-12-21 /pmc/articles/PMC9813933/ /pubmed/36620341 http://dx.doi.org/10.3748/wjg.v28.i47.6788 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Letter to the Editor
Deng, Chao-Lin
Wu, Bin
The potential role of the three-dimensional-bioprinting model in screening and developing drugs
title The potential role of the three-dimensional-bioprinting model in screening and developing drugs
title_full The potential role of the three-dimensional-bioprinting model in screening and developing drugs
title_fullStr The potential role of the three-dimensional-bioprinting model in screening and developing drugs
title_full_unstemmed The potential role of the three-dimensional-bioprinting model in screening and developing drugs
title_short The potential role of the three-dimensional-bioprinting model in screening and developing drugs
title_sort potential role of the three-dimensional-bioprinting model in screening and developing drugs
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813933/
https://www.ncbi.nlm.nih.gov/pubmed/36620341
http://dx.doi.org/10.3748/wjg.v28.i47.6788
work_keys_str_mv AT dengchaolin thepotentialroleofthethreedimensionalbioprintingmodelinscreeninganddevelopingdrugs
AT wubin thepotentialroleofthethreedimensionalbioprintingmodelinscreeninganddevelopingdrugs
AT dengchaolin potentialroleofthethreedimensionalbioprintingmodelinscreeninganddevelopingdrugs
AT wubin potentialroleofthethreedimensionalbioprintingmodelinscreeninganddevelopingdrugs